Top Markets
#1 Siren Siren +31.61%
#2 OriginTrail OriginTrail +29.02%
#3 Tutorial Tutorial +14.64%
#4 Waves Waves +11.24%
#5 Cortex Cortex +11.09%
#6 Synapse Synapse +10.97%
#7 MarsCoin MarsCoin +9.27%
#8 Pons Pons +8.17%
#9 TROLL TROLL +6.05%
#10 Concordium Concordium +5.93%
Coin of the day
Siren Siren
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

1762
Rang in aandelen #22434
Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co.,... Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.
Aandeelprijs
$1.15
Laatst gesynchroniseerd: 2026-08-21
Marktkapitalisatie
$88.79M
Verandering (1 dag)
2.54%
Verandering (1 jaar)
27.30%
Land
TW
Handel Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Categorie

Healthcare
Aandelsplitsingen voor Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)
Het aandeel Chunghwa Chemical Synthesis & Biotech Co., Ltd. (symbool: 1762) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 23, 2026.
Eén aandeel 1762 dat vóór Aug 23, 2026 werd gekocht, staat nu gelijk aan 0 aandelen 1762.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 0 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 0 -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 0 -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 0 -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 0 -
IT